FDA Inspection 646711 — Reckitt Benckiser, Inc.

Reckitt Benckiser, Inc. — FEI 1640689

The FDA completed an inspection of Reckitt Benckiser, Inc. on Feb 10, 2010 in Fort Worth, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 7 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Feb 10, 2010
Fiscal Year
2010
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Fort Worth, TX (United States)

Citations

IDCFRDescription
202721 CFR 211.192Investigations of discrepancies, failures
220521 CFR 211.186(b)(9)Manufacturing Instructions and Specifications
261921 CFR 211.198(b)(2)Complaint Investigation/Follow-Up Findings
357121 CFR 211.100(a)Changes to Procedures Not Reviewed, Approved
358521 CFR 211.110(a)Control procedures to monitor and validate performance
431421 CFR 211.84(d)(2)Reports of Analysis (Components)
890621 CFR 314.81(b)(1)(i)Mix-up

Need the full FDA record for Reckitt Benckiser, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.